Affordable Access

Access to the full text

Multiple sclerosis patients and COVID-19

Authors
  • Mado, Hubert1
  • Adamczyk-Sowa, Monika1
  • 1 Medical University of Silesia in Katowice, Poland, 3 Maja Street 13/15, Zabrze, 41-800, Poland , Zabrze (Poland)
Type
Published Article
Journal
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Publisher
Springer Berlin Heidelberg
Publication Date
Mar 23, 2021
Volume
57
Issue
1
Identifiers
DOI: 10.1186/s41983-021-00287-3
Source
Springer Nature
Keywords
License
Green

Abstract

Coronavirus disease 2019 (COVID-19) is now a major issue for all fields of medicine. Due to the higher mortality rate among patients with chronic diseases, it has also caused concern in patients with multiple sclerosis (MS), who in addition are often receiving immunosuppressive drugs. The aim of this article is to discuss what is currently known about the severity of COVID-19 in MS patients.

Report this publication

Statistics

Seen <100 times